BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12740151)

  • 1. Comparison of recombinant human luteinising hormone (r-hLH) and human menopausal gonadotropin (hMG) in assisted reproductive technology.
    Baer G; Loumaye E
    Curr Med Res Opin; 2003; 19(2):83-8. PubMed ID: 12740151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant gonadotropins.
    Lathi RB; Milki AA
    Curr Womens Health Rep; 2001 Oct; 1(2):157-63. PubMed ID: 12112963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current opinion on use of luteinizing hormone supplementation in assisted reproduction therapy: an Asian perspective.
    Wong PC; Qiao J; Ho C; Ramaraju GA; Wiweko B; Takehara Y; Nadkarni PV; Cheng LC; Chen HF; Suwajanakorn S; Vuong TN;
    Reprod Biomed Online; 2011 Jul; 23(1):81-90. PubMed ID: 21550853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation.
    Durnerin CI; Erb K; Fleming R; Hillier H; Hillier SG; Howles CM; Hugues JN; Lass A; Lyall H; Rasmussen P; Thong J; Traynor I; Westergaard L; Yates R;
    Hum Reprod; 2008 Feb; 23(2):421-6. PubMed ID: 18084048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of different gonadotropin combinations to support ovulation induction in WHO type I anovulation infertility: clinical evidences of human recombinant FSH/human recombinant LH in a 2:1 ratio and highly purified human menopausal gonadotropin stimulation protocols.
    Carone D; Caropreso C; Vitti A; Chiappetta R
    J Endocrinol Invest; 2012 Dec; 35(11):996-1002. PubMed ID: 23095369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology.
    Ezcurra D; Humaidan P
    Reprod Biol Endocrinol; 2014 Oct; 12():95. PubMed ID: 25280580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human LH supplementation versus supplementation with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol: a matched case-control study.
    Bühler KF; Fischer R
    Gynecol Endocrinol; 2012 May; 28(5):345-50. PubMed ID: 22115012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study.
    Tarlatzis B; Tavmergen E; Szamatowicz M; Barash A; Amit A; Levitas E; Shoham Z
    Hum Reprod; 2006 Jan; 21(1):90-4. PubMed ID: 16172149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosing Characteristics of Recombinant Human Luteinizing Hormone or Human Menopausal Gonadotrophin-Derived LH Activity in Patients Undergoing Ovarian Stimulation: A German Fertility Database Study.
    Strezsak V; Allignol A; Bühler K; Fischer R; Hubbard J; Longobardi S; Lispi M; Schertz J; Verpillat P
    Gynecol Obstet Invest; 2023; 88(4):214-225. PubMed ID: 37369184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovulation induction: ovarian response to human gonadotropins and synthetic gonadotropin-releasing hormone.
    Zanartu J; Dabancens A; Rodriguez-Bravo R; Barsby F; Schally AV
    Obstet Gynecol; 1975 Apr; 45(4):443-50. PubMed ID: 47625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiles of cumulus cells obtained from women treated with recombinant human luteinizing hormone + recombinant human follicle-stimulating hormone or highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone alone.
    Gatta V; Tatone C; Ciriminna R; Vento M; Franchi S; d'Aurora M; Sperduti S; Cela V; Borzì P; Palermo R; Stuppia L; Artini PG
    Fertil Steril; 2013 Jun; 99(7):2000-8.e1. PubMed ID: 23472943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of LH and FSH in ovarian function.
    Howles CM
    Mol Cell Endocrinol; 2000 Mar; 161(1-2):25-30. PubMed ID: 10773387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human luteinizing hormone, lutropin alfa, for the induction of follicular development and pregnancy in profoundly gonadotrophin-deficient women.
    Kaufmann R; Dunn R; Vaughn T; Hughes G; O'Brien F; Hemsey G; Thomson B; O'Dea LS
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):563-9. PubMed ID: 17692110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG.
    Gomes MK; Vieira CS; Moura MD; Manetta LA; Leite SP; Reis RM; Ferriani RA
    Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):99-106. PubMed ID: 16835006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent progress in the hormonal treatment of sterility].
    Fanard A
    Brux Med; 1975 Jul; 55(7):401-14. PubMed ID: 1098749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary pharmacological manipulation in assisted reproduction.
    Huirne JA; Lambalk CB; van Loenen AC; Schats R; Hompes PG; Fauser BC; Macklon NS
    Drugs; 2004; 64(3):297-322. PubMed ID: 14871171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment.
    Marrs R; Meldrum D; Muasher S; Schoolcraft W; Werlin L; Kelly E
    Reprod Biomed Online; 2004 Feb; 8(2):175-82. PubMed ID: 14989794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures.
    Ruvolo G; Bosco L; Pane A; Morici G; Cittadini E; Roccheri MC
    Fertil Steril; 2007 Mar; 87(3):542-6. PubMed ID: 17126339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.